Your browser doesn't support javascript.
loading
Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.
Lemkes, Jorrit S; Janssens, Gladys N; Straaten, Heleen M Oudemans-van; Elbers, Paul W; van der Hoeven, Nina W; Tijssen, Jan G P; Otterspoor, Luuk C; Voskuil, Michiel; van der Heijden, Joris J; Meuwissen, Martijn; Rijpstra, Tom A; Vlachojannis, Georgios J; van der Vleugel, Raoul M; Nieman, Koen; Jewbali, Lucia S D; Bleeker, Gabe B; Baak, Rémon; Beishuizen, Bert; Stoel, Martin G; van der Harst, Pim; Camaro, Cyril; Henriques, José P S; Vink, Maarten A; Gosselink, Marcel T M; Bosker, Hans A; Crijns, Harry J G M; van Royen, Niels.
Affiliation
  • Lemkes JS; Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands. Electronic address: j.lemkes@vumc.nl.
  • Janssens GN; Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Straaten HM; Department of Intensive care medicine, VU University Medical Centre, Amsterdam, the Netherlands.
  • Elbers PW; Department of Intensive care medicine, VU University Medical Centre, Amsterdam, the Netherlands.
  • van der Hoeven NW; Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Tijssen JG; Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.
  • Otterspoor LC; Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
  • Voskuil M; Department of Cardiology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • van der Heijden JJ; Department of Intensive care medicine, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Meuwissen M; Department of Cardiology, Amphia Hospital, Breda, the Netherlands.
  • Rijpstra TA; Department of Intensive care medicine, Amphia Hospital, Breda, the Netherlands.
  • Vlachojannis GJ; Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.
  • van der Vleugel RM; Department of Intensive care medicine, Maasstad Hospital, Rotterdam, the Netherlands.
  • Nieman K; Thoraxcenter, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Jewbali LS; Thoraxcenter, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Bleeker GB; Department of Cardiology, HAGA Hospital, Den Haag, the Netherlands.
  • Baak R; Department of Intensive care medicine, HAGA Hospital,Den Haag, the Netherlands.
  • Beishuizen B; Department of Intensive care medicine, Medical Centre Twente, Enschede, the Netherlands.
  • Stoel MG; Department of Cardiology, Medical Centre Twente, Enschede, the Netherlands.
  • van der Harst P; Department of Cardiology, University Medical Centre, Groningen, the Netherlands.
  • Camaro C; Department of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Henriques JP; Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.
  • Vink MA; Department of Cardiology, OLVG hospital, Amsterdam, the Netherlands.
  • Gosselink MT; Department of Cardiology, Isala klinieken, Zwolle, the Netherlands.
  • Bosker HA; Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Crijns HJ; Department of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • van Royen N; Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands.
Am Heart J ; 180: 39-45, 2016 Oct.
Article in En | MEDLINE | ID: mdl-27659881
BACKGROUND: Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role of immediate coronary angiography (CAG) and percutaneous coronary intervention (PCI) after restoration of spontaneous circulation following cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) remains debated. HYPOTHESIS: We hypothesize that immediate CAG and PCI, if indicated, will improve 90-day survival in post-cardiac arrest patients without signs of STEMI. DESIGN: In a prospective, multicenter, randomized controlled clinical trial, 552 post-cardiac arrest patients with restoration of spontaneous circulation and without signs of STEMI will be randomized in a 1:1 fashion to immediate CAG and PCI (within 2 hours) versus initial deferral with CAG and PCI after neurological recovery. The primary end point of the study is 90-day survival. The secondary end points will include 90-day survival with good cerebral performance or minor/moderate disability, myocardial injury, duration of inotropic support, occurrence of acute kidney injury, need for renal replacement therapy, time to targeted temperature control, neurological status at intensive care unit discharge, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, and reasons for discontinuation of treatment. SUMMARY: The COACT trial is a multicenter, randomized, controlled clinical study that will evaluate the effect of an immediate invasive coronary strategy in post-cardiac arrest patients without STEMI on 90-day survival.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Coronary Angiography / Out-of-Hospital Cardiac Arrest / Percutaneous Coronary Intervention Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: Am Heart J Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Coronary Angiography / Out-of-Hospital Cardiac Arrest / Percutaneous Coronary Intervention Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: Am Heart J Year: 2016 Type: Article